The Fresenius Medical Care (FMC) ST share was subjected to a thorough examination by DZ Bank. These are the results found.
DZ Bank left the classification for Fresenius Medical Care (FMC) on “Buy” with a fair value of 60 euros after numbers for the second quarter. The dialysis company defied the effects of flu waves, wrote Sven Kürten in a study available on Friday. The stock returns drove his estimates for the profit per share, and the medium -term outlook is strong.
Shares Check: A detailed look at the performance of the Fresenius Medical Care (FMC) ST share at the time of the analysis
The paper from Fresenius Medical Care (FMC) ST gave up at 1:24 p.m. and rose by 1.2 percent to EUR 43.05 in Xetra trading. 123,776 Fresenius Medical Care (FMC) ST shares recently changed the owner via Xetra. The share certificate has increased by 0.2 percent since the beginning of 2025.
Frankfurt (dpa-afx analysis) / editorial finance.net
Publication of the original study: 15.08.2025 / 09:00 / time zone in study not specified for the first time passing on of the original study: 15.08.2025 / 09:07 / time zone not specified in study
Note: Information on the obligation to disclose the disclosure for conflicts of interest within the meaning of Section 85 (1) WPHG, Art. 20 VO (EU) 596/2014 For the Analysten House mentioned can be found at http://web.dpa-afx.de/offengegungs-
Selected leverage products on Fresenius Medical Care (FMC) St.
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Fresenius Medical Care (FMC) St.
The lever must be between 2 and 20
Advertising